,i  #aaeth ,,congress  #b;d ,session    
,h4 ,r4 #fadb  ,,in ,,the ,,house ,,of  
,,representatives  ,june #ai1 #bjah,mr4 
,doggett introduced the following bill2 
which was referred to the ,committee on 
,energy and ,commerce  ,a ,,bill  ,to   
authorize a joint action plan and report
 on drug waste4  #a4 ,short title ,this 
,act may be cited as the ,reducing ,drug
 ,waste ,act of #bjah4  #b4 ,joint      
action plan and report on drug waste    
7a7 ,joint action plan ,the ,secretary  
of ,health and ,human ,services1 shall  
develop a joint action plan1 in         
consultation with stakeholders such as  
health care providers and patient       
advocates 7including relevant ,federal  
advisory committees71 that--  7#a7      
utilizes data from ,medicare claims on  
how much of a single-use drug was not   
administered1 comparing single-use vial 
sizes in other settings such as to other
 countries' health care systems1 and    
through analysis during the drug        
approval process of alternative vial    

size safety and efficacy1 to reduce drug
 waste and better manage costs2  7#b7   
includes quantifiable metrics and       
specific timelines to adopt different   
vial sizes in addition to those         
currently approved and marketed in the  
,united ,states in order to             
significantly reduce the amount of drug 
discards1 or waste1 from single-use     
vials2 and  7#c7 includes options for   
how to better manage costs1 including   
new technologies related to capture and 
storage1 while ensuring patient access4 
7b7 ,report ,not later than #a year     
after the date of enactment of this     
,act1 the ,secretary of ,health and     
,human ,services shall submit to        
,congress the joint action plan         
described in subsection 7a7 and a report
 containing options for any legislative 
action needed to reduce drug waste and  
better manage costs4